Advertisement

Compliance Costs for Regulatory Approval of New Biotech Crops

  • Nicholas Kalaitzandonakes
  • Julian M. Alston
  • Kent J. Bradford
Part of the Natural Resource Management and Policy book series (NRMP, volume 30)

Abstract

The regulatory approval process for new biotech crop varieties is said to be unduly slow and expensive, presenting important barriers to the development of new cropping technologies. To date, however, the private and social costs have not been analyzed or measured, let alone compared with alternatives. This chapter reports initial findings from our continuing project on the costs of regulatory compliance for biotech crops. In this chapter we describe and document the regulatory requirements, and we provide estimates of representative compliance costs for key biotechnologies based on confidential data supplied to us by several major biotech companies.

Key words

biotechnology regulatory approval compliance costs cost estimates 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alston, J.M. 2004. “Horticultural Biotechnology Faces Significant Economic and Market Barriers.” California Agriculture 58(2): 80–88.CrossRefGoogle Scholar
  2. Alston, J.M., J. Hyde, M.C. Marra, and P.D. Mitchell. 2002. “An Ex Ante Analysis of the Benefits from the Adoption of Corn Rootworm Resistant, Transgenic Corn Technology.” AgBioForum 5(3): 71–84.Google Scholar
  3. Belson, N.A. 2000. “U.S. Regulation of Agricultural Biotechnology: An Overview.” AgBio-Forum 3(4): 268–280.Google Scholar
  4. Bradford, K.J., J.M. Alston, and N. Kalaitzandonakes. 2006. “Regulation of Biotechnology for Specialty Crops.” In R.E. Just, J.M. Alston, and D. Zilberman, eds., Regulating Agricultural Biotechnology: Economics and Policy. New York: Springer.Google Scholar
  5. Bradford, K.J., J.M. Alston, D.A. Sumner, and P. Lemaux (eds.). 2004. “Challenges and Opportunities for Horticultural Biotechnology.” California Agriculture 58(2): 68–71.Google Scholar
  6. Bradford, K.J., A. Van Deynze, N. Gutterson, W. Parrott, and S.H. Strauss. 2005. “Regulating Transgenic Crops Sensibly: Lessons from Plant Breeding, Biotechnology and Genomics.” Nature Biotechnology 23(April 6): 439–444.PubMedCrossRefGoogle Scholar
  7. Cellini, F., A. Chesson, I. Colquhoun, A. Constable, H.V. Davies, K.H. Engel, A.M.R. Gatehouse, S. Kärenlampi, E.J. Kok, J.-J. Leguay, S. Lehesranta, H.P.J.M. Noteborn, J. Pedersen, and M. Smith. 2004. “Unintended Effects and Their Detection in Genetically Modified Crops.” Food and Chemical Toxicology 42(7): 1089–1125.PubMedCrossRefGoogle Scholar
  8. Falck-Zepeda, J., G. Traxler, and R. Nelson. 2000. “Surplus Distribution from the Introduction of a Biotechnology Innovation.” American Journal of Agricultural Economics 82(2): 360–369.CrossRefGoogle Scholar
  9. Gianessi, L.P., C.S. Silvers, S. Sankula, and J.E. Carpenter. 2002. “Plant Biotechnology: Current and Potential Impact for Improving Pest Management in U.S. Agriculture: An Analysis of 40 Case Studies.” National Center for Food and Agricultural Policy, Washington, D.C. Available at http://www.ncfap.org/40CaseStudies.htm (August 10, 2005).Google Scholar
  10. Huang, J., S. Rozelle, C. Pray, and Q. Wang. 2002. “Plant Biotechnology in the Developing World: The Case of China.” Science 295(25): 674–677.PubMedCrossRefADSGoogle Scholar
  11. Jaffe, G. 2005. “Withering on the Vine: Will Agricultural Biotechnology’s Promise Bear Fruit?” Center for Science in the Public Interest, Washington D.C. Available at http://cspinet.org/new/pdf/withering_on_the_vine.pdf (accessed July 31, 2005).Google Scholar
  12. James, C. 2004. “Preview: Global Status of Commercialized Biotech/GM Crops: 2004.” ISAAA Briefs No. 32, International Service for the Acquisition of Agri-Biotech Applications, Ithaca, NY. Available at http://www.isaaa.org (accessed May 7, 2005).Google Scholar
  13. Kalaitzandonakes, N. (ed.). 2003. “Economic and Environmental Impacts of Agbiotech: A Global Perspective.” New York: Kluwer-Plenum Academic Publishers.Google Scholar
  14. Kalaitzandonakes, N. 2004. “Another Look at Biotech Regulation.” Regulation 27(1): 44–50.Google Scholar
  15. Kapuscinski, A.R., S. Goodman, L. Hann, E. Jacobs, C. Pullins, J. Johnson, R. Kinsey, A. Krall, M. LaVina, M. Mellon, and V. Ruttan. 2003. “Making Safety First a Reality for Biotechnology Products.” Nature Biotechnology 21(6): 599–601.PubMedCrossRefGoogle Scholar
  16. Marra, M., P. Pardey, and J. Alston. 2002. “The Payoffs to Transgenic Field Crops: An Assessment of the Evidence.” AgBioForum 5(2): 43–50.Google Scholar
  17. McElroy, D. 2003. “Sustaining Agrobiotechnology Through Lean Times.” Nature Biotechnology 21(9): 996–1002.Google Scholar
  18. Miller, H., and G. Conko. 2005. “Agricultural Biotechnology: Overregulated and Underappreciated.” Issues in Science and Technology 21(2): 76–81.Google Scholar
  19. Pew Initiative on Food and Biotechnology. 2004. “Issues in the Regulation of Genetically Engineered Plants and Animals.” The Pew Initiative on Food and Biotechnology, Washington, D.C. Available at http://pewagbiotech.org/research/regulation/request.php (accessed August 10,2005).Google Scholar
  20. U.S. Department of Agriculture. 2005. “Field Testing Database.” Animal and Plant Health Inspection Service, U.S. Department of Agriculture, Washington, D.C. Available at http://www.aphis.usda.gov/brs/database.html (accessed May 13, 2005).Google Scholar
  21. U.S. National Academy of Sciences. 2000. Genetically Modified Pest-Protected Plants: Science and Regulation. Washington, D.C: National Academy Press.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Nicholas Kalaitzandonakes
    • 1
  • Julian M. Alston
    • 2
  • Kent J. Bradford
    • 2
  1. 1.University of Missouri-ColumbiaColumbia
  2. 2.University of CaliforniaDavis

Personalised recommendations